“…Both Flynn and Pfizer appealed to the CAT. The CAT recognised in its substantive decision the “importance of this case for the public interest”: [2018] CAT 11 at [5]. After a four week trial, the CAT found that although Flynn and Pfizer held dominant positions in the market in question, the CMA had made errors in dec…”
“…The Tribunal handed down the Judgment on 7th July 2018: [2018] CAT 11. It found that: (i) the CMA had correctly identified the relevant geographical and product markets; (ii) Pfizer and Flynn were dominant in those markets; but (…”
“…petition Appeal Tribunal (“the Tribunal”). The appeal was heard during October and November 2017. Judgment was handed down on 7th June 2018 and is reported at: [2018] CAT 11 (“the Judgment”). The Tribunal upheld the conclusion of the CMA that the relevant markets in which to assess the alleged dominance of Pfizer and Flynn were (i)…”